AI assistant
Sending…
DAVITA INC. — Director's Dealing 2015
Jun 4, 2015
30643_dirs_2015-06-04_a4f00a9f-0beb-48de-aa11-6d186b2045d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2015-06-02
Reporting Person: Rodriguez Javier (CEO, Kidney Care)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-02 | Stock Appreciation Rights | $83.82 | A | 46551 | Acquired | 2020-06-02 | Common Stock (46551) | Direct |
Footnotes
F1: Stock Appreciation Rights granted on 6/2/2015, which vest 50% each on 6/2/2018 and 6/2/2019.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25